
Tetrabenazine-d6 New

* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS No. | 1392826-25-3 | Cat. No. | BCP16001 |
Name | Tetrabenazine-d6 | ||
Synonyms | SD809; SD-809; SD 809; Deutetrabenazine;Ro 1-9569 D6; GTPL8707;Tetrabenazine D6; | ||
SMILES | |||
Chemical Name | |||
Formula | C19H27NO3 | M. Wt | 317.42 |
Purity | 98% | Storage | Store at 4-8°C |
Description | Tetrabenazine-d6, also known as SD-809 and Deutetrabenazine, is an investigational, oral, small-molecule inhibitor of vesicular monoamine 2 transporter, or VMAT2, that is designed to regulate the levels of a specific neurotransmitter, dopamine, in the brain. Deutetrabenazine is a deuterated tetrabenazine. SD-809 is being developed for the treatment of chorea associated with Huntington’s disease, a neurodegenerative movement disorder that impacts cognition, behavior, and movements. Teva is investigating the broad potential of SD-809 for treating additional movements disorders such as tardive dyskinesia and tics associated with Tourette syndrome. |
Recommend Products
More >Tags:Tetrabenazine-d6 supplier,Tetrabenazine-d6 purchase,Tetrabenazine-d6 manufacturer,Tetrabenazine-d6 distributor,Tetrabenazine-d6 cost,Tetrabenazine-d6 buy,Tetrabenazine-d6 for sale